Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low- versus high-dose hydrocortisone replacement in secondary adrenal insufficiency
NL-OMON38411Phase 4Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hydrocortisone in Adrenocorticotropic hormone (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Cognitive performance. Started May 2012; status: active, not recruiting.
02
Drugs
hydrocortisone
03
Conditions
Adrenocorticotropic hormone
Beyond the preview
Go deeper on NL-OMON38411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38411.